Rethinking thrombophilia testing in pediatric VTE: A decade of real-world evidence

Mahdi Asleh1, Hadeel Musa2, Shirly Ammar3

  • 1Pediatric Hemato-oncology Department, Saban Pediatric Medical Center, Soroka University Medical Center, Beer Sheva, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Thrombosis Research
|December 27, 2025
PubMed

Insights

Routine thrombophilia testing in children with venous thromboembolism (VTE) did not change anticoagulation duration or predict recurrence. Selective testing is recommended over routine screening after a first VTE event.

Area of Science:

  • Pediatric Hematology
  • Thrombosis Research
  • Clinical Outcomes Analysis

Background:

  • The clinical value of routine thrombophilia testing in pediatric venous thromboembolism (VTE) management remains controversial.
  • This study aimed to assess the real-world impact of thrombophilia testing on treatment and patient outcomes.

Purpose of the Study:

  • To evaluate if thrombophilia testing influences anticoagulation duration in pediatric VTE patients.
  • To determine the association between thrombophilia status and VTE recurrence and thrombus resolution.

Main Methods:

  • A 10-year retrospective cohort study included 67 pediatric patients diagnosed with VTE.
  • Analysis focused on the relationship between thrombophilia status and anticoagulation duration, VTE recurrence rates, and imaging-confirmed thrombus resolution.

Main Results:

  • A positive thrombophilia workup did not significantly alter anticoagulation duration compared to negative results.
  • Thrombophilia status was not a significant predictor of VTE recurrence.
  • Positive thrombophilia workup was associated with a higher rate of Residual Vein Obstruction (RVO), but RVO did not predict recurrence.

Conclusions:

  • Thrombophilia testing in pediatric VTE patients did not impact treatment duration or recurrence prediction.
  • Findings support current guidelines favoring selective, clinically guided thrombophilia testing over routine use after an initial pediatric VTE event.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
257
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
266
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
267
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
176
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
274